Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for January 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Amgen to expand R&D investment in UK
World's largest biotech to open new R&D centre in Uxbridge..(more)

 Eisai invests £75 million in UK for new European base
First Japanese company to set up manufacturing in UK..(more)

 Merck battling more lawsuits over Vioxx
Merck vows to 'conduct vigorous defence' in Texas court ..(more)

 Humira becomes Britain's first biotech blockbuster
Drug could open up new business avenues for CAT..(more)

 Limited access to Alzheimer's drugs leaves patients groups dissatisfied
Campaigners hope NICE changes its mind after consultation..(more)

 Roche and biotech swap roles in novel collaboration
Companies leverage inflammation expertise..(more)

 Prescribers ready to defy NICE in Alzheimer's drug row
Psychiatrists say their patients must have access..(more)

 Next generation monoclonal antibodies to enter clinical trials in 2007
Novartis signs 'Nanobody' deal with Belgium biotech ..(more)

 Next generation hypertension drug ready for 2006 filing
Novartis confirms Rasilez on track for early 2006 US filing ..(more)

 Wyeth submits follow-up to antidepressant blockbuster
New drug potential successor to top-selling Efexor..(more)

 Campaign to raise awareness of pharma code of conduct
Sante to launch PR campaign in April..(more)

 Mergers will create gulf between GPs and PCTs
NHS Alliance warns of gulf between managers and clinicians..(more)

 FDA looks to streamline early research
Initiative part of FDA's critical path plan..(more)

 Patient-led NHS revolution to continue, says under fire Hewitt
Hewitt to press ahead with Labour's NHS reforms..(more)

 StayinFront wins Roche regional contract
Pharma company to use StayinFront Life Sciences system..(more)

 First-in-class indication expected for Remicade
Schering-Plough expects European approval in early 2006..(more)

 Virgo Health wins Cymbalta account
Virgo to promote antidepressant to healthcare professionals..(more)

 Drinking straw a novel antibiotic delivery for children
Clarosip helps the medicine go down..(more)

 Novartis to appeal Zelnorm rejection
CHMP refuses marketing authorisation..(more)

 Gene discovery offers new diabetes drug target hope
Icelandic company looks to crack gene code..(more)

 Pfizer to go it alone with Exubera
Pfizer buys out Sanofi-Aventis' stake in Exubera..(more)

 Merck in race to bring first cervical cancer vaccine to market
Merck files Gardasil in US and GSK unveils new clinical trial..(more)

 Patients unaware as flagship NHS choice scheme launched
Patients to choose from list of at least four hospitals..(more)

 Programme exposes counterfeit dangers
Programme makers obtain wholesale licence fraudulently..(more)

 GlaxoSmithKline considering Serono acquisition
Novartis also tipped as possible suitor..(more)

 New dawn or beginning of the end? Medicare D comes of age
Most significant US health insurance reform for 40 years..(more)

 Action needed on prostate cancer services
Prostate cancer patients given lowest priority..(more)

 Packer Forbes wins Remicade and Altana accounts
Schering-Plough appoints agency to provide PR for top seller ..(more)

 Bayer buys hypertension drug rights from GSK
Deal strengthens BI's relationship with Bayer..(more)

 PCT merger plans 'ill conceived'
Government plans to restructure NHS condemned in report..(more)

 AstraZeneca buys UK cancer research firm
AstraZeneca tries to bolster oncology pipeline..(more)

 Pharma unprepared for shift to secondary care
Pharma pipelines shifting from primary to secondary care..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.